Mast Cells and Basophils in Major Viral Diseases: What Are the Correlations with SARS-CoV-2, Influenza A Viruses, HIV, and Dengue?

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI

Basophils*/immunology ; COVID-19*/immunology ; COVID-19*/virology ; SARS-CoV-2*/immunology ; Mast Cells*/immunology ; Mast Cells*/virology ; Dengue*/immunology ; Dengue*/virology ; HIV Infections*/immunology ; HIV Infections*/virology ; Influenza, Human*/immunology ; Influenza, Human*/virology; Humans ; Influenza A virus/immunology ; Immunity, Innate

The SARS-CoV-2 pandemic has significantly impacted global health and has led the population and the scientific community to live in fear of a future pandemic. Based on viral infectious diseases, innate immunity cells such as mast cells and basophils play a fundamental role in the pathogenesis of viral diseases. Understanding these mechanisms could be essential to better study practical therapeutic approaches not only to COVID-19 but also to other viral infections widely spread worldwide, such as influenza A, HIV, and dengue. In this literature review, we want to study these concepts. Mast cells and basophils intervene as a bridge between innate and acquired immunity and seem to have a role in the damage mechanisms during infection and in the stimulation of humoral and cellular immunity. In some cases, these cells can act as reservoirs and favor the replication and spread of the virus in the body. Understanding these mechanisms can be useful not only in therapeutic but also in diagnostic and prognostic perspectives. The prospects of applying artificial intelligence and machine learning algorithms for the creation of very accurate diagnostic/prognostic tools are interesting.

Lab Invest. 2017 Feb 27;97(5):602-614. (PMID: 28240747)
Emerg Microbes Infect. 2023 Dec;12(2):2251589. (PMID: 37606034)
Immun Inflamm Dis. 2016 Dec 11;5(1):7-15. (PMID: 28250920)
PLoS Pathog. 2023 May 18;19(5):e1011406. (PMID: 37200384)
Front Microbiol. 2017 Jan 12;7:2130. (PMID: 28127293)
Proc Natl Acad Sci U S A. 2011 May 31;108(22):9190-5. (PMID: 21576486)
J Med Virol. 2004 Jun;73(2):230-4. (PMID: 15122797)
J Biol Regul Homeost Agents. 2020 Oct 5;34(5):1633-1636. (PMID: 33023287)
Semin Respir Crit Care Med. 2016 Aug;37(4):487-500. (PMID: 27486731)
Am J Respir Cell Mol Biol. 1992 Oct;7(4):434-40. (PMID: 1382480)
Signal Transduct Target Ther. 2021 Dec 17;6(1):428. (PMID: 34921131)
J Biol Regul Homeost Agents. 2020 Sep 18;34(5):1629-1632. (PMID: 32945158)
Viruses. 2021 May 12;13(5):. (PMID: 34066286)
Clin Biochem. 2023 Aug;118:110584. (PMID: 37211061)
Autoimmun Rev. 2024 Feb;23(2):103496. (PMID: 38081493)
Medicine (Baltimore). 2024 Nov 1;103(44):e40384. (PMID: 39496030)
J Leukoc Biol. 2006 Dec;80(6):1242-50. (PMID: 16940332)
Clin Lab. 2023 Apr 1;69(4):. (PMID: 37057951)
PLoS One. 2012;7(3):e34055. (PMID: 22479521)
J Immunol. 2013 May 1;190(9):4676-84. (PMID: 23526820)
Virol J. 2024 Jun 24;21(1):143. (PMID: 38915037)
J Clin Invest. 2019 Jul 2;129(10):4180-4193. (PMID: 31265436)
Blood. 2001 Jun 1;97(11):3484-90. (PMID: 11369641)
Open Biol. 2018 Aug;8(8):. (PMID: 30135238)
Front Public Health. 2022 May 24;10:880999. (PMID: 35677769)
J Virol. 2012 Mar;86(6):3347-56. (PMID: 22238293)
Sci Rep. 2024 Jan 20;14(1):1783. (PMID: 38245638)
PLoS One. 2014 Jun 12;9(6):e100109. (PMID: 24923273)
J Immunol. 2016 Dec 1;197(11):4382-4391. (PMID: 27799312)
BMC Med. 2024 Mar 7;22(1):105. (PMID: 38454462)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
J Ayub Med Coll Abbottabad. 2023 Feb-Mar;35(1):80-83. (PMID: 36849382)
Cells. 2021 Oct 14;10(10):. (PMID: 34685733)
Allergy. 1990 Aug;45(6):471-6. (PMID: 1700890)
Crit Rev Immunol. 2000;20(6):477-96. (PMID: 11396683)
Agents Actions. 1989 Apr;27(1-2):58-61. (PMID: 2473634)
Int Arch Allergy Immunol. 2001 Jun;125(2):89-95. (PMID: 11435725)
Int J Gen Med. 2023 Aug 31;16:3955-3962. (PMID: 37670931)
Virol Sin. 2024 Apr;39(2):309-318. (PMID: 38458399)
Immunol Rev. 2001 Feb;179:128-38. (PMID: 11292016)
Allergy. 2023 Feb;78(2):369-388. (PMID: 36420736)
Front Immunol. 2021 Mar 10;12:650331. (PMID: 33777047)
Medicine (Baltimore). 2024 May 17;103(20):e38117. (PMID: 38758896)
Trends Mol Med. 2012 Mar;18(3):182-92. (PMID: 22240486)
Antiviral Res. 2019 Nov;171:104566. (PMID: 31348951)
Immunology. 2015 Sep;146(1):163-72. (PMID: 26059780)
J Virol. 2002 Aug;76(16):8408-19. (PMID: 12134044)
Front Immunol. 2023 May 16;14:1166574. (PMID: 37261339)
Clin Mol Allergy. 2016 Nov 1;14:15. (PMID: 27822141)
J Immunol. 2009 May 15;182(10):6401-9. (PMID: 19414793)
J Clin Invest. 2023 Oct 2;133(19):. (PMID: 37561585)
Trends Immunol. 2001 May;22(5):229-32. (PMID: 11323269)
Elife. 2013 Apr 30;2:e00481. (PMID: 23638300)
Front Microbiol. 2022 Feb 07;13:798660. (PMID: 35197951)
Curr Opin Immunol. 2000 Dec;12(6):624-31. (PMID: 11102764)
Allergy. 1988 Feb;43(2):93-9. (PMID: 2452582)
J Virol. 2017 Aug 24;91(18):. (PMID: 28659489)
J Allergy Clin Immunol. 2001 Jan;107(1):22-30. (PMID: 11149986)
Influenza Other Respir Viruses. 2016 Jan;10(1):57-66. (PMID: 26176755)
Sci Rep. 2022 Oct 29;12(1):18262. (PMID: 36309538)
J Virol. 2011 Jan;85(2):1145-50. (PMID: 21068256)
J Virol. 2012 Jun;86(12):6408-15. (PMID: 22496214)
Front Immunol. 2020 Sep 11;11:552909. (PMID: 33013925)
FEBS Lett. 2019 Sep;593(18):2612-2627. (PMID: 31271652)
Front Immunol. 2022 Feb 24;13:838448. (PMID: 35280992)
Viruses. 2022 Jan 29;14(2):. (PMID: 35215885)
Hum Immunol. 2015 May;76(5):318-23. (PMID: 25797204)
Blood. 2019 May 23;133(21):2325-2337. (PMID: 30755421)
Vaccines (Basel). 2020 May 03;8(2):. (PMID: 32375243)
J Allergy Clin Immunol. 2020 Jul;146(1):128-136.e4. (PMID: 32425269)
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006841. (PMID: 22229120)
J Virol. 2000 Aug;74(15):7146-50. (PMID: 10888655)
Cells. 2024 Jan 17;13(2):. (PMID: 38247864)
Eur J Pharmacol. 2022 Sep 5;930:175169. (PMID: 35921955)
Southeast Asian J Trop Med Public Health. 1977 Mar;8(1):80-3. (PMID: 887998)
J Med Virol. 2024 Jun;96(6):e29736. (PMID: 38864349)
Front Genet. 2019 Jun 21;10:595. (PMID: 31281330)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Life Sci. 2020 Oct 1;258:118230. (PMID: 32777303)
J Infect Dis. 2017 Nov 27;216(9):1112-1121. (PMID: 28968807)
Cell Host Microbe. 2020 Jun 10;27(6):883-890.e2. (PMID: 32407669)
Ann Allergy Asthma Immunol. 2021 Mar;126(3):217-218. (PMID: 33161155)
J Med Virol. 2021 Jun;93(6):3330-3337. (PMID: 32857465)
Soft comput. 2023;27(6):3295-3306. (PMID: 34025211)
Int J Mol Sci. 2019 Aug 30;20(17):. (PMID: 31480219)
Int Arch Allergy Immunol. 2016;171(3-4):158-165. (PMID: 27960171)
Viruses. 2022 Nov 21;14(11):. (PMID: 36423184)
Nat Med. 2020 Oct;26(10):1636-1643. (PMID: 32839624)
BMC Infect Dis. 2008 Jun 25;8:86. (PMID: 18578883)

Keywords: COVID-19; HIV; adaptive immune response; basophils; dengue; influenza virus; innate immune response; mast cells

Date Created: 20250108 Date Completed: 20250108 Latest Revision: 20250114

20250115

PMC11674676

10.3390/cells13242044

39768136